These dying patients cannot get experimental drugs


By AGENCY

Autumn Fuernisen was diagnosed four years ago with a terminal brain disorder, juvenile-onset Huntington's disease. Patients with rare diseases often have difficulty qualifying for compassionate use programs for experimental therapies.- Londen Tabor/TNS

AT 15, Autumn Fuernisen is dying.

She was diagnosed at age 11 with a rare degenerative brain disorder that has no known cure or way to slow it down: juvenile-onset Huntington’s disease.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Health

Why rescue blankets have a silver and a gold side
'Engage your core!' – but how do you really do that?
Region-specific diets around China recommended to combat obesity
It’s tough becoming a dad – and they get little support too
A tired brain leads to bad decisions and bad behaviour
Diabetes: Empowering communities with peer support and social media
Lower your blood pressure by swapping just a few minutes of sitting for exercise
When uncontrolled diabetes causes you to go blind
New ways to combat the threat of antimicrobial resistance (AMR)
Prenetics and David Beckham launch IM8 brand with two health and wellness supplements

Others Also Read